Status:
UNKNOWN
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
Lead Sponsor:
Heidelberg University
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-...
Detailed Description
NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Samples are collected before surgery or before any therapy
- ECOG 0 or 1
- Clinical stage I-II, T1-2, N0-1, M0)
- Surgically respectable
- Patient with enlarged med. lymphnodes (control group)
Exclusion
- Previous RT/CHT
- Previous or current cancer of other entity
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00982605
Start Date
October 1 2009
End Date
January 1 2011
Last Update
October 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
Heidelberg, Germany, 69126